دورية أكاديمية
أعرض في EDS

Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.

التفاصيل البيبلوغرافية
العنوان: Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
المؤلفون: Moar P; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, USA., Linn K; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Premeaux TA; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, USA., Bowler S; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, USA., Sardarni UK; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, USA., Gopalan BP; Division of infectious diseases, St. John's Research Institute, Bengaluru, India.; Sickle Thrombosis and Vascular Biology Lab, Sickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, USA., Shwe EE; Department of Pathology, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., San T; Department of Pathology, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Han H; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Clements D; Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu., Hlaing CS; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Kyu EH; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Thair C; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Mar YY; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Nway N; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Mannarino J; Missouri Institute of Mental Health, University of Missouri-St. Louis, Missouri., Bolzenius J; Missouri Institute of Mental Health, University of Missouri-St. Louis, Missouri., Mar S; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Aye AMM; Department of Pediatrics, Yangon Children's Hospital, University of Medicine 1, Yangon, Myanmar., Tandon R; Laboratory of AIDS Research and Immunology, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India., Paul R; Missouri Institute of Mental Health, University of Missouri-St. Louis, Missouri., Ndhlovu LC; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, USA.
المصدر: AIDS (London, England) [AIDS] 2024 Aug 01; Vol. 38 (10), pp. 1460-1467. Date of Electronic Publication: 2024 Apr 26.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE
أسماء مطبوعة: Publication: 1998- : London, England : Lippincott Williams & Wilkins
Original Publication: London : Gower Academic Journals, c1987-
مواضيع طبية MeSH: Galectins*/blood , HIV Infections*/drug therapy , HIV Infections*/psychology , HIV Infections*/complications , Inflammation*/blood, Humans ; Male ; Adolescent ; Female ; Cross-Sectional Studies ; India ; Cognition ; Plasma ; Flow Cytometry ; Immunoassay ; Infectious Disease Transmission, Vertical ; Biomarkers/blood ; Child
مستخلص: Objective: Adolescents with perinatally acquired HIV (AWH) are at an increased risk of poor cognitive development yet the underlying mechanisms remain unclear. Circulating galectin-9 (Gal-9) has been associated with increased inflammation and multimorbidity in adults with HIV despite antiretroviral therapy (ART); however, the relationship between Gal-9 in AWH and cognition remain unexplored.
Design: A cross-sectional study of two independent age-matched cohorts from India [AWH on ART ( n  = 15), ART-naive ( n  = 15), and adolescents without HIV (AWOH; n  = 10)] and Myanmar [AWH on ART ( n  = 54) and AWOH ( n  = 22)] were studied. Adolescents from Myanmar underwent standardized cognitive tests.
Methods: Plasma Gal-9 and soluble mediators were measured by immunoassays and cellular immune markers by flow cytometry. We used Mann-Whitney U tests to determine group-wise differences, Spearman's correlation for associations and machine learning to identify a classifier of cognitive status (impaired vs. unimpaired) built from clinical (age, sex, HIV status) and immunological markers.
Results: Gal-9 levels were elevated in ART-treated AWH compared with AWOH in both cohorts (all P  < 0.05). Higher Gal-9 in AWH correlated with increased levels of inflammatory mediators (sCD14, TNFα, MCP-1, IP-10, IL-10) and activated CD8 + T cells (all P  < 0.05). Irrespective of HIV status, higher Gal-9 levels correlated with lower cognitive test scores in multiple domains [verbal learning, visuospatial learning, memory, motor skills (all P  < 0.05)]. ML classification identified Gal-9, CTLA-4, HVEM, and TIM-3 as significant predictors of cognitive deficits in adolescents [mean area under the curve (AUC) = 0.837].
Conclusion: Our results highlight a potential role of Gal-9 as a biomarker of inflammation and cognitive health among adolescents with perinatally acquired HIV.
(Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.)
References: J Infect Dis. 2001 Sep 15;184(6):699-706. (PMID: 11517430)
Clin Infect Dis. 2017 Jan 15;64(2):132-133. (PMID: 27965300)
Lancet Child Adolesc Health. 2020 Sep;4(9):688-698. (PMID: 32359507)
AIDS. 2014 Jan 28;28(3):355-64. (PMID: 24670521)
Clin Infect Dis. 2015 Apr 1;60(7):1111-9. (PMID: 25516183)
J Neuroinflammation. 2014 Aug 27;11:144. (PMID: 25158758)
PLoS Pathog. 2016 Jun 02;12(6):e1005677. (PMID: 27253379)
Cell Immunol. 2021 Mar;361:104287. (PMID: 33494007)
J Immunol. 2012 Dec 15;189(12):5896-902. (PMID: 23180819)
J Immunol. 2020 May 1;204(9):2474-2491. (PMID: 32205423)
J Acquir Immune Defic Syndr. 2019 May 1;81(1):102-109. (PMID: 30768490)
Clin Dev Immunol. 2012;2012:805151. (PMID: 22550537)
Clin Exp Immunol. 2007 Dec;150(3):442-50. (PMID: 17956580)
Pediatr Infect Dis J. 2012 Jun;31(6):583-91. (PMID: 22333700)
Turk J Emerg Med. 2018 Aug 07;18(3):91-93. (PMID: 30191186)
Immunohorizons. 2019 Nov 15;3(11):531-546. (PMID: 31732662)
Ment Retard Dev Disabil Res Rev. 2006;12(3):223-8. (PMID: 17061290)
Issues Compr Pediatr Nurs. 2008 Jul-Sep;31(3):107-21. (PMID: 18728957)
PLoS Biol. 2021 Aug 19;19(8):e3001387. (PMID: 34411088)
JAMA. 1996 Feb 28;275(8):606-10. (PMID: 8594241)
FASEB J. 2021 Jul;35(7):e21556. (PMID: 34137463)
J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):371-9. (PMID: 21646912)
Genes Cells. 2009 Apr;14(4):511-21. (PMID: 19335620)
Indian J Psychol Med. 2014 Jul;36(3):255-9. (PMID: 25035547)
J Neurovirol. 2023 Jun;29(3):337-345. (PMID: 37233903)
J Reprod Immunol. 2005 Aug;66(2):175-91. (PMID: 16029895)
Brain Behav Immun. 2021 Jan;91:65-73. (PMID: 32860940)
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10650-5. (PMID: 21670307)
Viruses. 2019 Feb 27;11(3):. (PMID: 30818749)
J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):42-9. (PMID: 23982657)
J Acquir Immune Defic Syndr. 2020 May 1;84(1):114-121. (PMID: 32032303)
Nutr Metab (Lond). 2016 Apr 30;13:31. (PMID: 27134637)
Int J Infect Dis. 2013 Oct;17(10):e862-7. (PMID: 23562357)
AIDS. 2022 Nov 15;36(14):1917-1925. (PMID: 35848569)
Pediatr Neurol. 2015 Dec;53(6):485-490.e1. (PMID: 26386698)
J Neurovirol. 2019 Apr;25(2):150-161. (PMID: 30478799)
AIDS Res Ther. 2020 Jul 16;17(1):43. (PMID: 32678033)
mBio. 2021 May 4;12(3):. (PMID: 33947753)
AIDS. 2021 Dec 1;35(15):2489-2495. (PMID: 34366381)
PLoS One. 2012;7(10):e47648. (PMID: 23112829)
Sci Rep. 2019 May 29;9(1):8004. (PMID: 31142789)
Sci Rep. 2018 Dec 5;8(1):17679. (PMID: 30518941)
PLoS One. 2012;7(6):e38708. (PMID: 22685601)
Neurology. 2010 Dec 7;75(23):2087-96. (PMID: 21135382)
Inflammation. 2017 Jun;40(3):1062-1071. (PMID: 28393295)
Child Adolesc Psychiatry Ment Health. 2022 Apr 27;16(1):31. (PMID: 35477577)
J Infect Dis. 2007 Dec 1;196(11):1667-70. (PMID: 18008251)
AIDS. 2021 Jul 15;35(9):1375-1384. (PMID: 33710019)
Viruses. 2021 Dec 18;13(12):. (PMID: 34960812)
J Immunol. 2005 Sep 1;175(5):2974-81. (PMID: 16116184)
Curr Opin HIV AIDS. 2016 Mar;11(2):146-55. (PMID: 26679413)
Pediatr Infect Dis J. 2000 Sep;19(9):862-71. (PMID: 11001110)
AIDS Res Hum Retroviruses. 2014 Jul;30(7):654-64. (PMID: 24786365)
Rev Med Virol. 2014 Sep;24(5):316-31. (PMID: 24806816)
Curr HIV/AIDS Rep. 2022 Feb;19(1):121-132. (PMID: 35107809)
PLoS One. 2017 Dec 29;12(12):e0190332. (PMID: 29287090)
J Immunother Cancer. 2020 Dec;8(2):. (PMID: 33310773)
AIDS. 2010 Jun 19;24(10):1481-91. (PMID: 20539091)
PLoS One. 2012;7(9):e45733. (PMID: 23029209)
Microbiol Spectr. 2023 Sep 7;:e0125623. (PMID: 37676005)
معلومات مُعتمدة: R01 MH108559 United States MH NIMH NIH HHS; R01 MH112457 United States MH NIMH NIH HHS
المشرفين على المادة: 0 (Galectins)
0 (LGALS9 protein, human)
0 (Biomarkers)
تواريخ الأحداث: Date Created: 20240412 Date Completed: 20240711 Latest Revision: 20240715
رمز التحديث: 20240715
مُعرف محوري في PubMed: PMC11239096
DOI: 10.1097/QAD.0000000000003907
PMID: 38608008
قاعدة البيانات: MEDLINE
الوصف
تدمد:1473-5571
DOI:10.1097/QAD.0000000000003907